Mayne Pharma's core product portfolio encompasses a specialized range of pharmaceutical therapeutics focused primarily on dermatology, women's health, and metabolic disorders. Among its flagship branded commercial offerings is Nextstellis, an innovative oral contraceptive tablet, alongside specialized dermatological treatments like Doryx for acne management and various topical creams. Additionally, the company manufactures and distributes an extensive portfolio of generic prescription medications, complex oral drug delivery formulations utilizing proprietary technologies, and specialized pharmacy distribution services managed through its expanding digital health infrastructure platforms.